Home
  • Home
  • Resources
  • Diseases
  • Training
  • Evaluation
    • The Tool
    • The Tutorial
  • SYSVAC
    • About
    • Registry
    • E-learning courses
  • News
  • Webinars
  • Network
    • Steering Committee
    • Vision and Mission
    • Map
    • Meetings
    • Partners
    • Join us
  • Home
  • Resources
  • Grading of Recommendations Assessment, Development and Evaluation (GRADE) of a 2-dose schedule for human papillomavirus (HPV) vaccination
Resources / NITAG documentation

Grading of Recommendations Assessment, Development and Evaluation (GRADE) of a 2-dose schedule for human papillomavirus (HPV) vaccination

Download:
  • EN
Information
Author(s):
ACIP
Source(s):
https://www.cdc.gov/vaccines/acip/recs/grade/hpv-2-dose.html
Publication year:
2016
Abstract

After reviewing the available data, including the result of the GRADE analysis, ACIP voted in October 2016 to recommend a 2-dose schedule of HPV vaccine for girls and boys who initiate the vaccination series at ages 9 through 14 years (Category A recommendation). See Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices.

Background paper Americas United States of America
  • Home
  • Resources
  • Diseases
  • Training
  • Evaluation
  • SYSVAC
  • News
  • Webinars
  • Network
  • Sign in / Register
National Immunization Technical Advisory Groups
  • Home
  • Resources
  • Diseases
  • Training
  • Evaluation
  • SYSVAC
  • News
  • Webinars
  • Network
© 2025
  • Legal Notice
Subscription to the monthly updates

At the end of each month, we share the latest NITAG recommendations from across all regions, highlight key articles related to NITAG activities, and provide important announcements. Stay informed - don’t miss out!

Loading...